This test is most useful if any of these apply to you.
Your standard blood sugar tests can tell you whether glucose is already out of range, but they cannot tell you whether you are running low on one of the raw materials your body uses to process that sugar in the first place. Blood chromium is that raw material. Lower levels have been linked to higher rates of type 2 diabetes, insulin resistance, and metabolic syndrome in multiple large human studies, yet chromium is never included on a routine metabolic panel.
This is a newer measurement without standardized clinical cutpoints, and major authorities still debate whether chromium is truly an essential nutrient. That means a single reading should not drive major medical decisions on its own. But getting a baseline now and tracking your trend gives you data to compare against as the science matures, especially if you already have metabolic risk factors.
Chromium exists in two main forms. The form found in food and supplements is trivalent chromium, sometimes written as Cr(III). This is the form your body uses, and it is what a blood chromium test measures. The other form, hexavalent chromium or Cr(VI), is an industrial pollutant and a known cancer-causing substance, but it is not what this test is about.
Trivalent chromium appears to support the way insulin works at the cellular level, helping your cells take up glucose from the bloodstream. It has also been linked to fat and cholesterol processing. However, the European Food Safety Authority (EFSA) has concluded that the evidence is too limited to confirm chromium as essential for humans, and no recommended daily intake has been set at the international level. This puts chromium in an unusual position: it is widely sold as a supplement for blood sugar support, but the science behind that claim is still evolving.
The strongest human evidence connecting blood chromium to health outcomes comes from diabetes and pre-diabetes research. In a large Chinese study comparing people with and without diabetes (a design called a case-control study), researchers enrolled over 4,400 people and found that those in the highest quarter of plasma chromium levels had about 42% lower odds of having type 2 diabetes compared to those in the lowest quarter, after adjusting for age, sex, BMI, and other risk factors. People with pre-diabetes showed a similar pattern.
A separate analysis from NHANES (the U.S. National Health and Nutrition Examination Survey), covering nearly 2,900 adults aged 40 and older, found that men with low blood chromium (below 0.7 micrograms per liter) had roughly double the odds of diabetes compared to men with normal chromium levels. That association held after accounting for BMI, medications, and other health conditions.
In a Chinese matched case-control study of over 4,200 people, plasma chromium levels were lower in those with metabolic syndrome (a cluster of conditions including high blood sugar, excess belly fat, and abnormal cholesterol). People in the highest quarter of chromium had about 38% lower odds of metabolic syndrome. The association appeared to be driven primarily by links between higher chromium and lower waist circumference, lower triglycerides, and lower blood glucose.
These are all observational findings. They show a consistent pattern, but they cannot prove that low chromium causes diabetes or metabolic syndrome. It is possible that poorly controlled blood sugar drives chromium out of the body faster, making low chromium a consequence rather than a cause.
A smaller body of evidence links chromium to cardiovascular risk. In the NHANES dataset, men with low blood chromium had about 86% higher odds of self-reported cardiovascular disease after adjustment.
A long-term tracking study in Spain (the Hortega Follow-Up Study) of about 1,170 adults found that people at the 80th percentile of urinary chromium had roughly 64% higher risk of developing cardiovascular disease compared to those at the 20th percentile. This finding uses urinary chromium, which is a related but different measurement than blood chromium. In the Hortega study, urinary metals were measured as markers of environmental exposure, not nutritional status. Higher urinary chromium in that context may reflect greater environmental chromium exposure rather than better chromium nutrition, so this finding should not be interpreted the same way as the blood chromium data above.
A study in Pakistan measuring chromium at a single point in time found that among diabetic patients, those with cardiovascular complications had significantly lower serum chromium than those without. While interesting, this design cannot establish whether low chromium preceded the cardiovascular disease or resulted from it.
One of the largest datasets on chromium and aging analyzed over 51,000 samples from more than 40,000 people referred to a medical research laboratory. Chromium levels in hair, sweat, and serum all showed a strong decline with age, and men had significantly lower levels than women. The correlation between age and declining chromium was strong (a statistical correlation of roughly negative 0.6 to negative 0.76, where negative 1.0 would be a perfect inverse relationship). This age-related decline may partly explain why metabolic disease risk rises as people get older, though that link remains speculative.
There is no internationally agreed clinical reference range for blood chromium. The numbers below come from population studies using different methods and should be treated as rough orientation, not firm targets. Your own lab may use different units or cutpoints.
| Source | Specimen | Range Reported | Notes |
|---|---|---|---|
| CDC/NHANES (U.S. adults 40+) | Whole blood (ICP-MS) | 0.7 to 28.0 µg/L | Below 0.7 µg/L used as "low" in research |
| Barcelona population study (243 healthy adults) | Plasma (graphite furnace AAS) | 0.6 to 6.0 nmol/L (mean 3.01) | No sex-based differences found |
| China Nutrition Survey (1,400 pregnant women) | Serum (ICP-MS) | Median 835.6 ng/L (range 219.8 to 4,287.7) | Pregnancy-specific values |
Because the laboratory techniques used to measure chromium vary widely, comparing your result to numbers from a different lab or study can be misleading. The most meaningful comparison is always your own values over time, measured at the same lab.
The biggest source of error with blood chromium is variability between laboratory methods. Different labs use different analytical techniques (such as graphite furnace atomic absorption and inductively coupled plasma mass spectrometry, two specialized methods for detecting trace metals), and results can differ substantially between them. Always compare your results within the same lab.
Evidence-backed interventions that affect your Chromium level
Chromium is best interpreted alongside these tests.